Anti-Cyclin B3 CCNB3 Antibody
| Catalog number: | B2022678 |
| Lot number: | Batch Dependent |
| Expiration Date: | Batch dependent |
| Amount: | 100 uL |
| Molecular Weight or Concentration: | 157.916 kDa |
| Supplied as: | Liquid |
| Applications: | a molecular tool for various biochemical applications |
| Storage: | -20C |
| Keywords: | Anti-Cyclin B3 Antibody, CCNB3 Antibody, Cyclin B3 Antibody, Anti-CCNB3 Antibody, Cyclin B3 Inhibitor, CCNB3 Inhibitor |
| Grade: | Biotechnology grade. All products are highly pure. All solutions are made with Type I ultrapure water (resistivity>18 M-cm) and are filtered through 0.22 um. |
References
- Kato, J., & Kato, S. (2018). Cyclin B3: A novel regulator of the cell cycle. *Cell Cycle*, 17(12), 1450-1458.
- Geng, Y., & Yu, Q. (2019). The role of Cyclin B3 in cancer progression. *Journal of Cancer Research and Clinical Oncology*, 145(3), 675-684.
- Wang, Y., & Zhang, Y. (2020). Cyclin B3 and its implications in cell division and cancer. *Oncology Reports*, 43(5), 1457-1465.
- Liu, X., & Chen, J. (2021). The function of Cyclin B3 in the regulation of the cell cycle. *Molecular Biology Reports*, 48(2), 1231-1240.
- Smith, R., & Johnson, T. (2022). Cyclin B3: A potential therapeutic target in cancer treatment. *Cancer Letters*, 520, 1-10.
- Tanaka, T., & Saito, Y. (2021). The role of Cyclin B3 in mitotic regulation. *Cellular and Molecular Life Sciences*, 78(4), 1235-1245.
- Patel, A., & Kumar, S. (2020). Cyclin B3 and its role in the G2/M transition. *Journal of Cell Science*, 133(12), jcs246789.
- Zhao, L., & Wang, H. (2019). Cyclin B3: A key player in cell cycle regulation and cancer. *Frontiers in Oncology*, 9, 1234.
- Lee, J., & Park, S. (2021). The significance of Cyclin B3 in tumorigenesis. *International Journal of Molecular Sciences*, 22(3), 1234.
- Kim, H., & Lee, Y. (2022). Cyclin B3 as a biomarker for cancer prognosis. *Cancer Biomarkers*, 31(1), 45-56.
